When I use a word . . . . No jab, no job? A benefit:harm balance analysis
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions..
The current debate about whether individuals should be entitled to work in the healthcare sector if they decline to be vaccinated against SARS-CoV2 has been largely informed by personal opinions and argument by analogy. A benefit:harm balance analysis suggests that while vaccination has a highly favourable benefit:harm balance, the balance in instituting a "no jab, no job" policy is highly uncertain and may be unfavourable. Furthermore, there are practical difficulties and legal uncertainties. The much misunderstood precautionary principle dictates that if the benefit:harm balance of an intervention is unclear and may be unfavourable, the intervention should not be undertaken. Furthermore, the onus is on those who believe that the benefit:harm balance will be favourable to prove that it is so; it is not for the sceptics to prove that it isn't. In the absence of good evidence in favour, this is an intervention that would be best avoided.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:375 |
---|---|
Enthalten in: |
BMJ (Clinical research ed.) - 375(2021) vom: 26. Nov., Seite n2934 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Aronson, Jeffrey K [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 08.12.2021 Date Revised 02.09.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1136/bmj.n2934 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM333740084 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM333740084 | ||
003 | DE-627 | ||
005 | 20231225222252.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/bmj.n2934 |2 doi | |
028 | 5 | 2 | |a pubmed24n1112.xml |
035 | |a (DE-627)NLM333740084 | ||
035 | |a (NLM)34836888 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Aronson, Jeffrey K |e verfasserin |4 aut | |
245 | 1 | 0 | |a When I use a word . . . . No jab, no job? A benefit:harm balance analysis |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.12.2021 | ||
500 | |a Date Revised 02.09.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. | ||
520 | |a The current debate about whether individuals should be entitled to work in the healthcare sector if they decline to be vaccinated against SARS-CoV2 has been largely informed by personal opinions and argument by analogy. A benefit:harm balance analysis suggests that while vaccination has a highly favourable benefit:harm balance, the balance in instituting a "no jab, no job" policy is highly uncertain and may be unfavourable. Furthermore, there are practical difficulties and legal uncertainties. The much misunderstood precautionary principle dictates that if the benefit:harm balance of an intervention is unclear and may be unfavourable, the intervention should not be undertaken. Furthermore, the onus is on those who believe that the benefit:harm balance will be favourable to prove that it is so; it is not for the sceptics to prove that it isn't. In the absence of good evidence in favour, this is an intervention that would be best avoided | ||
650 | 4 | |a Editorial | |
650 | 7 | |a COVID-19 Vaccines |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t BMJ (Clinical research ed.) |d 1988 |g 375(2021) vom: 26. Nov., Seite n2934 |w (DE-627)NLM012612685 |x 1756-1833 |7 nnns |
773 | 1 | 8 | |g volume:375 |g year:2021 |g day:26 |g month:11 |g pages:n2934 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmj.n2934 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 375 |j 2021 |b 26 |c 11 |h n2934 |